XORTX Therapeutics
Price & Volume
Stats
See moreOpen | $0.56 |
Previous Close | $0.56 |
Day Range | $0.55-$0.56 |
52W Range | $0.51-$1.79 |
Market Cap | $3.9M |
Shares Short | 35,529 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.40 |
News
See moreYahoo Finance • 2 months ago
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
Yahoo Finance • 2 months ago
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
Yahoo Finance • 2 months ago
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Yahoo Finance • 2 months ago
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
About
CEO | Dr. Allen Warren Davidoff Ph.D. |
Address | 3710 ? 33rd Street NW, Calgary, AB, Canada, T2L 2M1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
